Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors

NCT06271109 | Enrolling By Invitation

• 1 other identifier: Soh-Med-24-01-04MD
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

aimed to discuss the short term surgical outcomes of Anatomical versus Non anatomical laparoscopic Liver resection for Liver tumors.

Conditions

Liver Neoplasms

Outcome Measures

Primary Outcomes (1)

• complete resection of the neoplasm

  to ensure complete resection with free resection margins

  3.5 years

Secondary Outcomes (2)

• residual liver tissue

  3.5 years

• recurrence rate

  3.5 years

Study Arms (2)

laparoscopic Anatomical liver resection

Procedure: Anatomical laparoscopic liver resection for liver neoplasms

laparoscopic Non Anatomical liver resection

Procedure: Non-Anatomical laparoscopic liver resection for liver neoplasms

Interventions

Anatomical laparoscopic liver resection for liver neoplasms PROCEDURE

resection of liver tumors laparoscopically based on surgical anatomical segmentation of the liver

laparoscopic Anatomical liver resection

Non-Anatomical laparoscopic liver resection for liver neoplasms PROCEDURE

resection of liver tumors laparoscopically not based on surgical anatomical segmentation of the liver

laparoscopic Non Anatomical liver resection

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patient with liver neoplasms candidate for resection and fit for surgery

You may qualify if:

• all patients diagnosed with liver tumors (benign and malignant) lesions suitable for laparoscopic liver resection (Anatomical and Non anatomical)
• Patients with Child Pugh A and early B
• Patients Fit for surgery as regard anesthesia
• Patients who accept to participate in the study and sign an informed consent

You may not qualify if:

• Patients with Child Pugh late B\&C liver disease.
• For Patients with hepatocellular carcinoma BCLC stage C\&D (extra hepatic spread and macro vascular invasion)
• Patients with contraindications to laparoscopic surgery and (or) unfit for surgery.

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag University

Sohag, Egypt

Location

MeSH Terms

Conditions

Liver Neoplasms

Condition Hierarchy (Ancestors)

Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Liver Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principle investigator

Study Record Dates

• First Submitted: February 5, 2024
• First Posted: February 21, 2024
• Study Start: December 1, 2021
• Primary Completion: June 1, 2025
• Study Completion: June 1, 2025
• Last Updated: February 21, 2024

Record last verified: 2024-02

Locations

EG (1)